Eikon Therapeutics, Inc. Common Stock ( EIKN) - Key Metrics
EIKN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$1.63 | -$1.20 | -$1.20 |
| 2026Q1 | $0 | -$1.53 | -$1.66 | -$1.66 |
| 2025Q4 | $0 | -$1.47 | -$0.77 | -$0.77 |
| 2025Q3 | $0 | $0 | $0 | $0 |
EIKN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -2.00 |
| 2026Q1 | 0% | -1.73 |
| 2025Q4 | 0% | -2.55 |
| 2025Q3 | 0% | 0 |
EIKN
Price: $10.75
52 week price:
Earnings Per Share: -5.95 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 598.5 million